Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
JAMA Neurology|December 20, 2021
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer DiseaseAntoine Leuzy, Ruben Smith, Nicholas C Cullen, et al.JAMA|October 17, 2018
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersRik Ossenkoppele, Gil D Rabinovici, Ruben Smith, et al.European Journal of Radiology|September 2, 2014
Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPDAlexandra R Morgan, Geoff J M Parker, Caleb Roberts, et al.Nature Communications|October 27, 2023
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseasesRuben Smith, Francesca Capotosti, Martin Schain, et al.Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 20, 2020
The impact of demographic, clinical, genetic, and imaging variables on tau PET statusRik Ossenkoppele, Antoine Leuzy, Hanna Cho, et al.JAMA Neurology|June 28, 2021
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance ImagingRik Ossenkoppele, Ruben Smith, Niklas Mattsson-Carlgren, et al.Pageof 6